New diabetes clinical trial: Siplizumab in T1DM

Published on: October 10, 2022 at 11:00AM
Condition:   Type 1 Diabetes Mellitus
Intervention:   Drug: Siplizumab
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting
https://ift.tt/2zq5GeJ